About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Effects of Renal Denervation on Insulin Sensitivity

NCT01631370·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Aarhus

Age

30–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Systolic daytime ambulatory BP at least 145 mmHg and compliance to a minimum of 3 antihypertensive drugs, including a diuretic

You may not be if

Diabetes
Pregnancy
Non compliance
Heart Failure (NYHA 3-4)
LV ejection fraction \< 50 %
Renal insufficiency (eGFR\<30)
Unstable coronary heart disease
Coronary intervention within 6 months
Myocardial infarction within 6 months
Claudication
Orthostatic syncope within 6 months
Secondary Hypertension
Permanent atrial fibrillation
Significant Heart Valve Disease
Clinically Significant abnormal electrolytes, haemoglobin, Liver enzymes, TSH
Second and third degree heart block
Macroscopic haematuria
Proximal significant coronary stenosis
Renal artery anatomy not suitable for renal artery ablation (Stenosis, small diameter \< 4 mm, length \< 2 cm, multiple renal arteries, severe calcifications)

The record

StatusCompleted

PhaseNo phase

Taking part8

StartedJun 2012

UpdatedMay 2, 2018

Conditions

Treatment Resistant Essential Hypertension Insulin Resistance

Where1

Medical Research Laboratories, Aarhus University Hospital
Aarhus, Denmark

Clareo Health | The Effects of Renal Denervation on Insulin Sensitivity